ECSP982489A - Formulaciones de proteina c activada - Google Patents
Formulaciones de proteina c activadaInfo
- Publication number
- ECSP982489A ECSP982489A ECSP982489A ECSP982489A EC SP982489 A ECSP982489 A EC SP982489A EC SP982489 A ECSP982489 A EC SP982489A EC SP982489 A ECSP982489 A EC SP982489A
- Authority
- EC
- Ecuador
- Prior art keywords
- activated protein
- formulations
- raffin
- mannite
- trehalose
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 101800004937 Protein C Proteins 0.000 abstract 1
- 102100036546 Salivary acidic proline-rich phosphoprotein 1/2 Human genes 0.000 abstract 1
- 101800001700 Saposin-D Proteins 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 abstract 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 abstract 1
- 239000004067 bulking agent Substances 0.000 abstract 1
- 239000012931 lyophilized formulation Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 229960000856 protein c Drugs 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
El invento se refiere a una formulación liofilizada estable que comprende proteína C activada y un agente voluminizante seleccionado del grupo consistente de manito, trealosa, rafinoa y sacarosa y mezclas similares de los mismos.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982489 ECSP982489A (es) | 1998-04-27 | 1998-04-27 | Formulaciones de proteina c activada |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982489 ECSP982489A (es) | 1998-04-27 | 1998-04-27 | Formulaciones de proteina c activada |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982489A true ECSP982489A (es) | 1999-04-13 |
Family
ID=42043410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982489 ECSP982489A (es) | 1998-04-27 | 1998-04-27 | Formulaciones de proteina c activada |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982489A (es) |
-
1998
- 1998-04-27 EC ECSP982489 patent/ECSP982489A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID24520A (id) | Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya | |
| DK1263720T3 (da) | Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme | |
| CY1116023T1 (el) | Μορφες φαρμακευτικης δοσολογιας παρατεταμενης απελευθερωσης με περιγραμματα διαλυτοποιησης ελαχιστοποιημενης εξαρτησης απο το ph | |
| DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
| PA8575701A1 (es) | Preparaciones acidas de insulina con estabilidad mejorada | |
| ES2173284T3 (es) | Agentes endoparasicitidas. | |
| ID24703A (id) | Kuinolon antimikroba, komposisi dan penggunaannya | |
| ATE380194T1 (de) | 6.alpha.,9.alpha.-difluoro-17.alpha.-(2- | |
| SV1997000079A (es) | Dihidrato d de olancepina ref. x- 11062t | |
| BR9710372B1 (pt) | composto, e, composiÇço farmacÊutica. | |
| SV2002000343A (es) | Composisiones farmaceuticas de inhibidores de la glucogeno fosforilasa ref. pc10882/20147/bb | |
| ES2130575T3 (es) | Composiciones inmunogenicas mejoradas contra la gastrina 17 humana. | |
| DE69933200D1 (de) | Kombinierte impfstoffzusammensetzungen | |
| AR027846A1 (es) | Componentes de formulacion estable, composiciones y metodos para el lavado que utilizan los mismos | |
| BR0010418B1 (pt) | microorganismo de salmonella, composiÇço de vacina e uso do referido microorganismo. | |
| DE10084671T1 (de) | Pharmazeutische Zusammensetzungen | |
| DE69912983D1 (de) | Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel | |
| MA26460A1 (fr) | Nouveaux inhibiteurs de farnesyle transferase, leur preparation, les compositions pharmaceutiques qui les contiennent. | |
| GT200000143A (es) | Empleo de formulaciones que contienen polisiloxano y agente deslizante de cadenas. | |
| MA26802A1 (fr) | Derives de streptogramine, leur preparation et les compositions qui les contiennent. | |
| NO20031860D0 (no) | Kahalaolid F | |
| AR027845A1 (es) | Aromatizacion que previene componentes de formulacion, composiciones y metodos de lavado que emplean los mismos | |
| BR0108075B1 (pt) | composição amaciante de tecido, e, uso de uma dispersão aquosa. | |
| CO4940362A1 (es) | Composiciones para esterilizar el pelo que poseen una mejor capacidad de ser eliminadas del pelo, que comprenden un co- polimero que contiene silicona y un disolvente para dicho copolimero | |
| DE50001659D1 (de) | Hartkaramellen mit verbesserter lagerstabilität |